AlphaFold predicted structure
ABHD16A · O95870

Mean pLDDT
89.6/ 100
Confident
558 residues
Confidence breakdown
- Very high(≥ 90)78%
- Confident(70–90)12%
- Low(50–70)4%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
abhydrolase domain containing 16A, phospholipase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Childhood onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalHereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalspastic paraplegia 86, autosomal recessive
Spastic paraplegia
Intellectual disability
complex hereditary spastic paraplegia
Autosomal recessive spastic paraplegia type 11
autosomal recessive complex spastic paraplegia
hereditary disease
neurodevelopmental disorder
gastric cancer
lipodystrophy, congenital generalized, type 5
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Phosphatidylserine lipase ABHD16A
Phosphatidylserine (PS) lipase that mediates the hydrolysis of phosphatidylserine to generate lysophosphatidylserine (LPS) (By similarity). LPS constitutes a class of signaling lipids that regulates immunological and neurological processes (By similarity). Has no activity towards diacylglycerol, triacylglycerol or lysophosphatidylserine lipase (PubMed:25290914). Also has monoacylglycerol lipase activity, with preference for 1-(9Z,12Z-octadecadienoyl)-glycerol (1-LG) and 2-glyceryl-15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ(2)-G) (PubMed:25290914)
ABHD16A · O95870

Mean pLDDT
89.6/ 100
Confident
558 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0